INSP vs PATH · P/E 9.4, rev $802.8M vs P/E 19, rev $1.61B
Inspire Medical Systems Inc (INSP) versus Uipath Inc (PATH) — a side-by-side from cached financials, not a winner call.
Inspire Medical Systems Inc (INSP) is a medical devices company listed on US.
Uipath Inc (PATH) is a software - infrastructure company listed on US.
Latest reported INSP revenue for 2024-12-31 was $802.8M. Net income was $53.5M. Revenue was up 28.5% from 2023-12-31 to 2024-12-31. INSP currently screens at market cap $1.19B and trailing P/E 9.4.
Latest reported PATH revenue for 2026-01-31 was $1.61B. Net income was $282.3M. Revenue was up 12.7% from 2025-01-31 to 2026-01-31. PATH currently screens at market cap $6.07B and trailing P/E 19.4.
INSP currently screens at market cap $1.19B and trailing P/E 9.4. PATH currently screens at market cap $6.07B and trailing P/E 19.4.
Not investment advice. Open the INSP and PATH stock pages for the full models.
Not investment advice.